GlassScriptPhysician profile
Alan R Koslow
NPI 1427004464
$3,760.15
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,365 · 2020: $890 · 2021: $195 · 2022: $311.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $598.39 | 2019-2022 | |
| Inari Medical, INC. | $407.59 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.76 | 2019 | |
| Lantheus Medical Imaging, INC. | $231.28 | 2019-2020 | |
| Tactile Systems Technology INC | $228.62 | 2020-2021 | |
| Organogenesis INC. | $228.18 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $228.18 | 2019 | |
| Novartis Pharmaceuticals Corporation | $221.83 | 2019-2020 | |
| Sanara Medtech INC. | $185.57 | 2022 | |
| Stryker Corporation | $156.51 | 2019 | |
| Osiris Therapeutics INC. | $149.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $146.34 | 2019 | |
| Portola Pharmaceuticals, LLC | $125.00 | 2019 | |
| Novo Nordisk INC | $116.29 | 2020 | |
| Abbott Laboratories | $113.09 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicure Pharma INC. | $102.20 | 2019 | |
| Sanofi-Aventis U.S. LLC | $93.42 | 2019 | |
| Acera Surgical, INC. | $68.75 | 2019 | |
| Alnylam Pharmaceuticals INC. | $64.55 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Koslow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.